World Top 100 Biotechnology Companies List by Market Cap as of August 2026

World Top 100 Biotechnology Companies List by Market Cap as of August 2026, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as of August 2026.

World Top Biotechnology Companies in 2026
World Largest Biotechnology Companies by Market Cap in 2026, World Top Biotechnology Companies by Market Cap in 2026.

  1. Annexon Inc.

    World Rank (Aug-2026)
    9,234
    Market Cap (Aug-2026)
    1.003 Billion USD
    World Rank (Jan-05-2024)
    14,389
    Market Cap (Jan-05-2024)
    0.375 Billion USD
    World Rank (Jul-30-2023)
    18,916
    Market Cap (Jul-30-2023)
    0.170 Billion USD
    World Rank (Dec-25-2022)
    16,605
    Market Cap (Dec-25-2022)
    0.260 Billion USD
    World Rank (Jan-07-2022)
    16,216
    Market Cap (Jan-07-2022)
    0.32 Billion USD
    Annual Operating Income in USD
    -216 Million USD
    Annual Net Income in USD
    -207 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Annexon Biosciences is a Clinical Stage Biopharmaceutical company discovering, developing and commercializing breakthrough therapeutics for autoimmune and neurodegenerative disease. It is having 38 employees as on September 2020. The headquarters is in USA.
    Company Website
    ANNEXON, INC.

  2. Saudi Pharmaceutical Industries & Medical Appliances Corporation

    World Rank (Aug-2026)
    9,285
    Market Cap (Aug-2026)
    0.995 Billion USD
    World Rank (Jan-05-2024)
    7,638
    Market Cap (Jan-05-2024)
    1.222 Billion USD
    World Rank (Jul-30-2023)
    7,551
    Market Cap (Jul-30-2023)
    1.277 Billion USD
    World Rank (Dec-25-2022)
    10,408
    Market Cap (Dec-25-2022)
    0.693 Billion USD
    World Rank (Jan-07-2022)
    8,198
    Market Cap (Jan-07-2022)
    1.27 Billion USD
    Annual Revenue in USD
    389 Million USD
    Annual Net Income in USD
    7 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Saudi Arabia
    Yahoo @ SaudiArabia
    Company Profile
    Saudi Pharmaceutical Industries & Medical Appliances Corporation is a medical and pharmaceutical company which includes development, manufacturing and sales of pharmaceutical products and medical appliances. The company annual revenue is 1,459 million SAR and annual net income is 26 million SAR for year ending December 2021. The headquarters is in Saudi Arabia.
    Company Website
    SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES CORPORATION

  3. Zhejiang Ausun Pharmaceutical

    World Rank (Aug-2026)
    9,290
    Market Cap (Aug-2026)
    0.994 Billion USD
    World Rank (Jan-05-2024)
    8,281
    Market Cap (Jan-05-2024)
    1.065 Billion USD
    World Rank (Jul-30-2023)
    7,737
    Market Cap (Jul-30-2023)
    1.225 Billion USD
    World Rank (Dec-25-2022)
    6,487
    Market Cap (Dec-25-2022)
    1.525 Billion USD
    World Rank (Jan-07-2022)
    7,500
    Market Cap (Jan-07-2022)
    1.48 Billion USD
    Headquarters Country
    China
    Yahoo @ Shanghai
    Company Website
    ZHEJIANG AUSUN PHARMACEUTICAL

  4. Janux Therapeutics Inc.

    World Rank (Aug-2026)
    9,315
    Market Cap (Aug-2026)
    0.986 Billion USD
    World Rank (Jan-05-2024)
    12,817
    Market Cap (Jan-05-2024)
    0.484 Billion USD
    World Rank (Jul-30-2023)
    11,423
    Market Cap (Jul-30-2023)
    0.617 Billion USD
    World Rank (Dec-25-2022)
    12,494
    Market Cap (Dec-25-2022)
    0.494 Billion USD
    World Rank (Jan-07-2022)
    10,875
    Market Cap (Jan-07-2022)
    0.77 Billion USD
    Annual Revenue in USD
    10 Million USD
    Annual Operating Income in USD
    -158 Million USD
    Annual Net Income in USD
    -114 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Website
    JANUX THERAPEUTICS, INC.

  5. Solid Biosciences

    World Rank (Aug-2026)
    9,317
    Market Cap (Aug-2026)
    0.986 Billion USD
    World Rank (Jan-05-2024)
    20,729
    Market Cap (Jan-05-2024)
    0.115 Billion USD
    World Rank (Jul-30-2023)
    22,447
    Market Cap (Jul-30-2023)
    0.086 Billion USD
    World Rank (Dec-25-2022)
    21,130
    Market Cap (Dec-25-2022)
    0.110 Billion USD
    World Rank (Jan-07-2022)
    19,806
    Market Cap (Jan-07-2022)
    0.17 Billion USD
    Annual Operating Income in USD
    -179 Million USD
    Annual Net Income in USD
    -174 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Solid Biosciences is a Life Science company focused on developing transformative treatments to improve the lives of patients living with Duchenne muscular dystrophy (Duchenne). The company estimated annual revenue is currently 12.4 million USD per year. The headquarters is in USA.
    Company Website
    SOLID BIOSCIENCES

  6. QuidelOrtho Corporation

    World Rank (Aug-2026)
    9,336
    Market Cap (Aug-2026)
    0.981 Billion USD
    World Rank (Jan-05-2024)
    2,991
    Market Cap (Jan-05-2024)
    4.855 Billion USD
    World Rank (Jul-30-2023)
    2,609
    Market Cap (Jul-30-2023)
    5.805 Billion USD
    World Rank (Dec-25-2022)
    2,474
    Market Cap (Dec-25-2022)
    5.594 Billion USD
    World Rank (Jan-07-2022)
    3,198
    Market Cap (Jan-07-2022)
    5.17 Billion USD
    Annual Revenue in USD
    2,730 Million USD
    Annual Operating Income in USD
    -919 Million USD
    Annual Net Income in USD
    -1,132 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Quidel Corporation is a Diagnostic Healthcare Manufacturer Serving company. It core competencies and capabilities include immunoassay development, automated manufacturing, monoclonal antibody characterization and development and molecular assay development. The company is delivering a continuum of diagnostic solutions from advanced lateral flow and direct fluorescent antibody to molecular diagnostic tests that further improve the quality of healthcare. The headquarters is in USA.

    Company Website
    QUIDEL CORPORATION

  7. Kura Oncology

    World Rank (Aug-2026)
    9,405
    Market Cap (Aug-2026)
    0.966 Billion USD
    World Rank (Jan-05-2024)
    7,868
    Market Cap (Jan-05-2024)
    1.161 Billion USD
    World Rank (Jul-30-2023)
    10,368
    Market Cap (Jul-30-2023)
    0.739 Billion USD
    World Rank (Dec-25-2022)
    9,716
    Market Cap (Dec-25-2022)
    0.781 Billion USD
    World Rank (Jan-07-2022)
    10,231
    Market Cap (Jan-07-2022)
    0.86 Billion USD
    Annual Revenue in USD
    67 Million USD
    Annual Operating Income in USD
    -304 Million USD
    Annual Net Income in USD
    -279 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Kura Oncology is a Clinical Stage Biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company total assets is 265.6 million USD and 134 employees as on 2019. The headquarters is in USA.
    Company Website
    KURA ONCOLOGY

  8. Shanghai Haohai Biological Technology

    World Rank (Aug-2026)
    9,437
    Market Cap (Aug-2026)
    0.959 Billion USD
    World Rank (Jan-05-2024)
    5,387
    Market Cap (Jan-05-2024)
    2.185 Billion USD
    World Rank (Jul-30-2023)
    5,795
    Market Cap (Jul-30-2023)
    1.974 Billion USD
    World Rank (Dec-25-2022)
    5,819
    Market Cap (Dec-25-2022)
    1.796 Billion USD
    World Rank (Jan-07-2022)
    4,973
    Market Cap (Jan-07-2022)
    2.89 Billion USD
    Annual Revenue in USD
    255 Million USD
    Annual Net Income in USD
    51 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    China
    Yahoo @ HongKong
    Company Website
    SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY

  9. Chemocentryx

    World Rank (Aug-2026)
    9,478
    Market Cap (Aug-2026)
    0.951 Billion USD
    World Rank (Jan-05-2024)
    5,410
    World Rank (Jul-30-2023)
    5,410
    World Rank (Dec-25-2022)
    5,410
    World Rank (Jan-07-2022)
    5,410
    Market Cap (Jan-07-2022)
    2.56 Billion USD
    Annual Revenue in USD
    32 Million USD
    Annual Operating Income in USD
    -130 Million USD
    Annual Net Income in USD
    -132 Million USD
    Annual Results for Period Ending
    For year ending December-2021
    Headquarters Country
    USA
    Company Profile
    ChemoCentryx is a Biopharmaceutical company. It portfolio of therapeutics in areas such as orphan and rare diseases, chronic kidney disease, immuno oncology and inflammatory and autoimmune diseases. The headquarters is in USA.
    Company Website
    CHEMOCENTRYX

  10. Geron Corporation

    World Rank (Aug-2026)
    9,506
    Market Cap (Aug-2026)
    0.944 Billion USD
    World Rank (Jan-05-2024)
    7,962
    Market Cap (Jan-05-2024)
    1.135 Billion USD
    World Rank (Jul-30-2023)
    6,549
    Market Cap (Jul-30-2023)
    1.618 Billion USD
    World Rank (Dec-25-2022)
    9,612
    Market Cap (Dec-25-2022)
    0.797 Billion USD
    World Rank (Jan-07-2022)
    15,170
    Market Cap (Jan-07-2022)
    0.38 Billion USD
    Annual Operating Income in USD
    -69 Million USD
    Annual Net Income in USD
    -84 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Geron Corporation is a Late Stage Clinical Biopharmaceutical company focused on the development and potential commercialization of a first in class telomerase inhibitor, imetelstat, an innovative therapeutic for hematologic myeloid malignancies. The headquarters is in USA.

    Facts About Company

    Geron Corporation Annual Total Revenue for year ending Dec-2022 was 0.5 million USD and and Net loss for year ending Dec-2022 was -141 million USD.

    Geron Corporation Annual Total Revenue for year ending Dec-2021 was 1.3 million USD and and Net loss for year ending Dec-2021 was =116 million USD.

    As on 2022, Geron Corporation has 107 employees.

    Company Website
    GERON CORPORATION
    Wikipedia
    Wikipedia

Share